BREXPIPRAZOLE AUGMENTATION ON MIRTAZAPINE FOR TREATMENT-RESISTANT DEPRESSION IN AN ELDERLY PATIENT
Journal: International Journal of Advanced Research (Vol.13, No. 05)Publication Date: 2025-05-20
Authors : Parinda Parikh Himani Suthar Parthiv Pansuriya Shauryakumar Singh Arnesh Shukla Aatish Bhatta Jeremy Kays Alisha Arul Alphonse Arushi Kaushik Chandra B.E Mahiya Buddhavarapu B.S Avinash Kesavarapu B.S Zoe Gellert B.S; Mina Oza;
Page : 1300-1303
Keywords : ;
Abstract
Treatment-resistant depression (TRD) poses a significant clinical challenge, particularly in elderly patients, due to age-related physiological changes, comorbidities, and reduced medication tolerability. TRD is generally defined as a major depressive disorder (MDD) that fails to respond to at least two adequate antidepressant trials.
Other Latest Articles
- COMPARISON OF DEXMEDETOMIDINE AND FENTANYL-MIDAZOLAM FOR TYMPANOPLASTY UNDER MONITORED ANAESTHESIA CARE
- UN-ETHICAL BEHAVIOUR AND THE CHALLENGE OF THE TWENTY- FIRST CENTUARY PUBLIC SERVICE IN NIGERI
- ANALYSE BIBLIOMETRIQUE SUR LA DYNAMIQUE PAYSAGERE DANS UN CONTEXTE DE CHANGEMENT CLIMATIQUE, BASEE SUR LA BASE DE DONNEES DIMENSIONS.AI ENTRE 2015 ET 2025
- EVALUATION OF BIOCHEMICAL AND HEMATOLOGICAL ALTERATIONS IN PATIENTS WITH CHOLELITHIASIS: A HOSPITAL-BASED CROSS-SECTIONAL STUDY
- BALANCING CONTROL AND AUTONOMY: A THREE-TIERED POLICY FRAMEWORK FOR STRENGTHENING ACADEMIC PUBLISHING IN INDIA
Last modified: 2025-06-19 16:30:33